Search
Search Funnelback University
1 -
10 of
13
search results for `Director of the Vasculitis and Lupus`
Fully-matching results
-
Wellcome Developing Concept Fund | Cambridge Academy of Therapeutic…
https://www.ats.cam.ac.uk/funding/wellcome-developing-concept-fund24 Jul 2024: Dr Dave Smith, Principal Scientist, AstraZeneca. Mr Stuart Kay, Director Medtech Solutions Ltd. ... Prof David Jayne, Director of the Vasculitis and Lupus Service, Addenbrooke’s Hospital. -
For staff - David Jayne
https://www.staff.admin.cam.ac.uk/taxonomy/term/3806/feed24 Jul 2024: basis.<br /> <strong>Dr David Jayne, Consultant in Nephrology and Vasculitis, Cambridge University Hospitals</strong><br /> David Jayne is an NHS consultant in nephrology and Director of the Vasculitis and Lupus ... biologic and other newer therapies in -
Clinical Research - Experimental Medicine and Immunotherapeutics…
https://emit.medschl.cam.ac.uk/research/clinicalresearch/23 Feb 2024: Professor Ian Wilkinson : Director of the new Cambridge University Health Partners’ Clinical Trials Unit. ... Professor David Jayne : Director of the Vasculitis and Lupus Service, Addenbrooke’s Hospital. -
CiC Expert Panel | Office for Translational Research
https://otr.medschl.cam.ac.uk/funding/confidence-concept/cic-expert-panel23 Feb 2024: Prof David Jayne, Director of the Vasculitis and Lupus Service, Cambridge University Hospitals NHS Foundation Trust. - ... Dr Sofia Villar, MRC Biostatistics Unit, University of Cambridge. - Mr David Warwick, Director, eg technology. - -
Professor David Jayne - Experimental Medicine and Immunotherapeutics…
https://emit.medschl.cam.ac.uk/people/investigators/dr-david-jayne/23 Feb 2024: Professor of Clinical Autoimmunity, University of Cambridge. Director of the Vasculitis and Lupus Service, Addenbrooke’s Hospital. ... Early phase clinical trials. Single and multi-centre clinical trials have been performed in ANCA vasculitis, -
Academy of Medical Sciences Success | For staff
https://www.staff.admin.cam.ac.uk/general-news/academy-of-medical-sciences-success24 May 2013: David Jayne is an NHS consultant in nephrology and Director of the Vasculitis and Lupus unit at Addenbrooke’s Hospital, Cambridge. ... biologic and other newer therapies in vasculitis, systemic lupus erythematosus and Behcet’s disease. -
For staff - David Ron
https://www.staff.admin.cam.ac.uk/taxonomy/term/3825/feed24 Jul 2024: basis.<br /> <strong>Dr David Jayne, Consultant in Nephrology and Vasculitis, Cambridge University Hospitals</strong><br /> David Jayne is an NHS consultant in nephrology and Director of the Vasculitis and Lupus ... biologic and other newer therapies in -
ADVANCING RESEARCH IN RENAL AUTOIMMUNITY A COLLABORATIVE SYMPOSIUM…
https://otr.medschl.cam.ac.uk/files/8_emi_autoimmunity_schedule_230120.pdf24 Nov 2022: Professor David Jayne Professor of Clinical Autoimmunity, University of Cambridge; Director of the Vasculitis and Lupus Service, Addenbrooke’s Hospital. ... He is head of the Nephrology outpatient clinic and coordinator of the Leiden outpatient clinic -
For staff - Jane Clarke
https://www.staff.admin.cam.ac.uk/taxonomy/term/4373/feed24 Jul 2024: basis.<br /> <strong>Dr David Jayne, Consultant in Nephrology and Vasculitis, Cambridge University Hospitals</strong><br /> David Jayne is an NHS consultant in nephrology and Director of the Vasculitis and Lupus ... biologic and other newer therapies in -
For staff - Ketan Patel
https://www.staff.admin.cam.ac.uk/taxonomy/term/4707/feed24 Jul 2024: basis.<br /> <strong>Dr David Jayne, Consultant in Nephrology and Vasculitis, Cambridge University Hospitals</strong><br /> David Jayne is an NHS consultant in nephrology and Director of the Vasculitis and Lupus ... biologic and other newer therapies in
Refine your results
Format
Date
- 11 Past 6 months
- 11 2024
- 11 Past year
- 8 Yesterday
- 8 Past 3 months
- 8 Past fortnight
- 8 Past month
- 8 Past week
- 1 2022
- 1 2013
Search history
Recently clicked results
Recently clicked results
Your click history is empty.
Recent searches
Recent searches
Your search history is empty.